10-Dehydrogingerdione raises HDL-cholesterol through a CETP inhibition and wards off oxidation and inflammation in dyslipidemic rabbits

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

William T. Friedewald, Robert I. Levy, Donald S. Fredrickson · Clinical Chemistry · 1972 · 32.5K citations

Life Sciences, Biochemistry, Clinical Biochemistry +14

Lipoprotein(a) as a cardiovascular risk factor: current status

Børge G. Nordestgaard, M. John Chapman, Kausik K. Ray et al. · European Heart Journal · 2010 · 1.8K citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

Christopher P. Cannon, Sukrut Shah, Hayes M. Dansky et al. · New England Journal of Medicine · 2010 · 754 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

Mi-Kyung Chang, Christoph J. Binder, Michael Torzewski et al. · Proceedings of the National Academy of Sciences · 2002 · 515 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

Michiel L. Bots, Frank L.J. Visseren, Gregory W. Evans et al. · The Lancet · 2007 · 458 citations

Medicine, Cardiology, Clinical Nutrition +8